5-HT1A RECEPTOR RESPONSIVITY IN UNIPOLAR DEPRESSION - EVALUATION OF IPSAPIRONE-INDUCED ACTH AND CORTISOL SECRETION IN PATIENTS AND CONTROLS

被引:154
作者
LESCH, KP
MAYER, S
DISSELKAMPTIETZE, J
HOH, A
WIESMANN, M
OSTERHEIDER, M
SCHULTE, HM
机构
[1] UNIV WURZBURG,DEPT PSYCHIAT,W-8700 WURZBURG,GERMANY
[2] UNIV KIEL,DEPT MED 1,W-2300 KIEL 1,GERMANY
关键词
D O I
10.1016/0006-3223(90)90400-V
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The selective 5-HT1A receptor ligand ipsapirone (IPS) induces corticotropin (ACTH) and cortisol secretion in humans. To explore 5-HT1A receptor-mediated hypothalamic-pituitary-adrenal (HPA) system activation in depression, 24 subjects (12 patients with unipolar depression and 12 individually matched controls) were given 0.3 mg/kg IPS or placebo in random order. Compared with controls, the depressed patients exhibited significantly decreased ACTH and cortisol responses to IPS in association with increased basal cortisol secretion. The impaired HPA response following 5-HT1A receptor challenge in unipolar depression could have resulted from glucocorticoid-dependent subsensitivity of the (post-synaptic) 5-HT1A receptor itself and/or from a defective postreceptor signaling pathway [inhibitory guanine nucleotide-binding protein (Gi)-adenylate cyclase complex function], thus supporting the hypothesis that a disintegrated 5-HT and HPA system interaction may be present in depression. Future studies of the HPA response to direct-acting 5-HT1A ligands, such as IPS, should facilitate the assessment of 5-HT/HPA system integrity in various affective disorders and its involvement in psychotropic drug effects. © 1990.
引用
收藏
页码:620 / 628
页数:9
相关论文
共 35 条
[1]   LONG-TERM CORTISOL TREATMENT IMPAIRS BEHAVIORAL AND NEURO-ENDOCRINE RESPONSES TO 5-HT1 AGONISTS IN THE RAT [J].
BAGDY, G ;
CALOGERO, AE ;
AULAKH, CS ;
SZEMEREDI, K ;
MURPHY, DL .
NEUROENDOCRINOLOGY, 1989, 50 (03) :241-247
[2]   PSYCHOTROPIC-DRUGS AND HUMAN 5-HT NEUROENDOCRINOLOGY [J].
COWEN, PJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (03) :105-108
[3]  
DEKLOET ER, 1986, NEUROENDOCRINOLOGY, V42, P513
[5]   PARAVENTRICULAR NUCLEUS SEROTONIN MEDIATES NEURALLY STIMULATED ADRENOCORTICAL SECRETION [J].
FELDMAN, S ;
CONFORTI, N ;
MELAMED, E .
BRAIN RESEARCH BULLETIN, 1987, 18 (02) :165-168
[6]  
FURMAN BL, 1989, PERIPHERAL ACTIONS 5, P282
[7]   EFFECT OF THE SEROTONIN REUPTAKE INHIBITOR FLUOXETINE ON CORTICOTROPIN-RELEASING FACTOR AND VASOPRESSIN SECRETION INTO HYPOPHYSEAL PORTAL BLOOD [J].
GIBBS, DM ;
VALE, W .
BRAIN RESEARCH, 1983, 280 (01) :176-179
[8]   ACTIVATION OF THE 5-HT1A RECEPTOR SUBTYPE INCREASES RAT PLASMA ACTH CONCENTRATION [J].
GILBERT, F ;
BRAZELL, C ;
TRICKLEBANK, MD ;
STAHL, SM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (03) :431-439
[9]  
GOLD PW, 1984, AM J PSYCHIAT, V141, P619
[10]   BIOCHEMISTRY, MOLECULAR-BIOLOGY, AND PHYSIOLOGY OF THE GLUCOCORTICOID RECEPTOR [J].
GUSTAFSSON, JA ;
CARLSTEDTDUKE, J ;
POELLINGER, L ;
OKRET, S ;
WIKSTROM, AC ;
BRONNEGARD, M ;
GILLNER, M ;
YU, D ;
FUXE, K ;
CINTRA, A ;
HARFSTRAND, A ;
AGNATI, L .
ENDOCRINE REVIEWS, 1987, 8 (02) :185-234